The results of the trial were published in Annals of Internal Medicine on June 30
Switch to a different one
Although there is a lack of direct studies on semaglutide, the observed actions align with those of other GLP-1R agonists, indicating a potential impact on cancer
You may be a candidate for non-surgical skin tightening if you have mild to moderate looseness and want a less invasive way to improve your appearance
With a Doctor-Led Weight Loss Program Found Pros Physicians specialize in weight loss, access to nutrition experts, health coaches Personalized weight loss plans, nutrition, exercise advice Can help navigate insurance coverage for GLP-1s Oral and injectable options available Semimonthly check-ins with clinician Cons Requires six-month commitment GLP-1 medications additional cost GLP-1 prescriptions require blood work Not available in all states Price Membership requires a six-month commitment
Eli Lillys retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, remains in Phase 3 TRIUMPH trials as of mid-2026, with NDA submission projected no earlier than Q4 2026